Kornitzer Capital Management Inc. KS reduced its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 12.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 72,356 shares of the pharmacy operator’s stock after selling 10,075 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Walgreens Boots Alliance were worth $4,002,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Usca Ria LLC increased its stake in Walgreens Boots Alliance by 0.7% in the third quarter. Usca Ria LLC now owns 27,587 shares of the pharmacy operator’s stock valued at $1,526,000 after purchasing an additional 190 shares during the period. Legacy Capital Partners Inc. increased its stake in Walgreens Boots Alliance by 1.6% in the third quarter. Legacy Capital Partners Inc. now owns 12,639 shares of the pharmacy operator’s stock valued at $699,000 after purchasing an additional 195 shares during the period. Chicago Capital LLC increased its stake in Walgreens Boots Alliance by 1.3% in the third quarter. Chicago Capital LLC now owns 15,425 shares of the pharmacy operator’s stock valued at $853,000 after purchasing an additional 200 shares during the period. First Bank & Trust increased its stake in Walgreens Boots Alliance by 6.3% in the third quarter. First Bank & Trust now owns 3,393 shares of the pharmacy operator’s stock valued at $187,000 after purchasing an additional 201 shares during the period. Finally, We Are One Seven LLC increased its stake in Walgreens Boots Alliance by 1.6% in the third quarter. We Are One Seven LLC now owns 12,954 shares of the pharmacy operator’s stock valued at $716,000 after purchasing an additional 208 shares during the period. 60.60% of the stock is owned by institutional investors and hedge funds.
Shares of NASDAQ:WBA traded up $0.57 during midday trading on Friday, hitting $59.24. The stock had a trading volume of 5,450,000 shares, compared to its average volume of 5,855,335. The stock has a 50 day moving average price of $55.10 and a two-hundred day moving average price of $53.53. The company has a current ratio of 0.73, a quick ratio of 0.36 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $54.63 billion, a PE ratio of 9.89, a P/E/G ratio of 1.53 and a beta of 0.87. Walgreens Boots Alliance Inc has a 1 year low of $49.03 and a 1 year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $33.95 billion during the quarter, compared to analyst estimates of $33.88 billion. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The company’s revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.48 earnings per share. As a group, equities analysts expect that Walgreens Boots Alliance Inc will post 5.93 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a $0.458 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.09%. The ex-dividend date is Friday, November 15th. Walgreens Boots Alliance’s dividend payout ratio is presently 30.55%.
WBA has been the topic of a number of recent research reports. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday. Cleveland Research reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Royal Bank of Canada downgraded shares of Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price on the stock. in a report on Friday, September 27th. Finally, Bank of America lowered their target price on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a report on Thursday, October 3rd. Five research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $61.35.
In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $63.16, for a total value of $14,801,861.80. Following the completion of the transaction, the chief accounting officer now owns 13,844 shares of the company’s stock, valued at $874,387.04. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Gap Up Stocks
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.